Article
The pattern of KRAS mutations in metastatic colorectal cancer: a retrospective audit from Sri Lanka.
BMC research notes - 10 Aug 2017
Sirisena Nirmala Dushyanthi, Deen Kemal, Mandawala Dayupathi Eranda Nipunika, Herath Pumindu, Dissanayake Vajira Harshadeva Weerabaddana
Abstract excerpt
OBJECTIVE: Activating mutations in the KRAS gene, found in approximately 53% of metastatic colorectal cancer (mCRC) cases, can render epidermal growth factor receptor (EGFR) inhibitors ineffective. Regional differences in these mutations have been reported. This is the first study which aims to describe the pattern of KRAS mutations in a Sri Lankan cohort of mCRC patients. RESULTS: The KRAS genotypes detected in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
